Stem Cell Clinic

Guide to Voting on Propositions and the City of San Bernardino’s Measure S – Black Voice News

By Stem Cell Doctors

Local Measure

San Bernardino Measure S

NO on Measure S in San Bernardino: It would raise taxes so the mayor can pay for sexual harassment lawsuits and give tax dollars to employees who work for the city but do not live in the city. Currently only 10% of the employees working for the city are Black and only 5% work in the police department. Only 8% of the sworn police officers live in the city and the city has never hired a Black as chief of police in 115 years. Blacks make up 13.8% of the city population and pay taxes.

Propositions

Proposition 14

NO on Prop 14: Taxpayers will be on the hook for $5.5 billion in bonds aimed at reviving the California Institute for Regenerative Medicine (CIRM), a program created in 2004 to boost stem cell research.

Proposition 15

NO on Prop 15: It would leave Californias Prop13 tax rules unchanged, which is a benefit to older Black homeowners. Small businesses will see their rents increase. This will hurt in the long run and the County Assessors offices up and down the state said it is unworkable.

Proposition 16

YES on Prop 16: It would be a giant step to help undo the results of long-standing institutionalized race and gender discrimination that have been key to economic and social inequality. This would put California back in step with Federal Laws governing Equal Opportunity in Employment, access to educational institutions of higher learning and provide fair access to government contracts for women and minority owned businesses.

Proposition 17

YES on Prop 17: It would make it legal for people who have paid their debt to society to vote while on parole for a felony conviction.

Proposition 18

YES on Prop 18: It would make it legal for people who will turn 18 in time for the general election to vote, even while still 17, at the time of that years primary.

Proposition 19

NO on Prop 19: Currently, a parent or grandparent can bestow their low tax rate while passing on a rental home or vacation property. This feature would be eliminated under Prop 19.

Proposition 20

NO on Prop 20: This initiative is being bankrolled by the states prison guards union and they are trying to keep the prisons full to protect their jobs. Plus, it will be unjust to Blacks and Hispanic people by adding stiffer penalties for those who violate the terms of their parole three times and require DNA samples be taken from people convicted of misdemeanors.

Proposition 21

NO on Prop 21: Some say it could make a dent in homelessness, a problem that is a crisis in our community. However, rent control does not work as some have learned and a rent board would be in charge of the owners property.

Proposition 22

YES on Prop 22: This initiative is about independent thinking people who use their own cars and cell phones to work when they want to, depending on their personal life situation. A yes vote will provide new benefits such as healthcare and a minimum wage. Plus, we have a lot of Black people who love working for themselves.

Proposition 23

NO on Prop 23: This legislation would require at least one physician to be on site at an operating dialysis clinic adding more expense to those who need the service. There are not enough doctors to do this work and the cost would eliminate many clinics in Black and Brown communities.

Proposition 24

NO on Prop 24: This measure would expand and add to Californias two-year-old law on consumer data privacy and create another layer to an already confusing system.

Proposition 25

NO on Prop 25: This is a risk assessment system that would replace cash bail and is biased because it uses a computer program that is inflexible to human special needs in this special time of need.

Hardy Brown Sr. is Publisher Emeritus of the Black Voice News.

Visit link:
Guide to Voting on Propositions and the City of San Bernardino's Measure S - Black Voice News

World Rose Day 2020: History and significance of the welfare of cancer patients – Hindustan Times

By Stem Cell Doctors

World Rose Day is annually celebrated on September 22 in dedication to the welfare of cancer patients. (Pixabay)

World Rose Day is annually celebrated on September 22 in dedication to the welfare of cancer patients. On this day, people around the world work towards bringing cheer and hope into the lives of all those people who have been affected by cancer. More importantly, it seeks to remind patients and their caregivers, that they are not alone in this battle against the deadly disease.

Cancer treatments are quite tasking on the body and mind of those who have been affected. With the changes their bodies encounter and the sheer mental trauma of being ravaged by this disease can wreak havoc with most people. According to Dr. Ganapathi Bhat, Consultant Medical Oncologist and Stem cell Transplant Physician at Jaslok Hospital & Research Centre, The financial costs associated with cancer are often overwhelming. Cancer affects a persons diet and eating habits in many ways. The illness can in itself cause weight loss, lack of appetite or other problems associated with eating. Cancer also often affects your self-image and self-esteem. Possible changes in physical appearance and depleted health can be frightening. Having cancer can undermine your mental and physical wellbeing. But by making even the simplest gestures of kindness, each and every one of us can bring some comfort to their lives. Even though that alone is not enough to cure them, it can certainly ease their suffering.

World Rose Day for the Welfare of Cancer Patients was first observed in honour of 12-year-old Melinda Rose from Canada, who was diagnosed with a rare form of blood cancer known as Askins Tumour. Even while the doctors had only given her weeks to live, she went on to live for 6 months and spent her time bringing joy and hope to all the diagnosed people around her. She reached out to all the cancer patients, sharing poems, letters and emails with them, to bring some cheer into their lives. Her kindness and optimism serve as a reminder to us all, that even in the most bleak of all situations, hope is what keeps us going.

By offering roses to cancer patients and their caregivers, people extend their concern and offer tenderness in the face of this harsh disease. Unfortunately, the medical and science fields are yet to come up with an absolute cure for cancer, despite their constant dedication to this cause, we can all contribute in our own way by being mindful of their suffering and ensuring that we care for them and contribute to their strength so that they may continue fighting.

Follow more stories on Facebook and Twitter

Here is the original post:
World Rose Day 2020: History and significance of the welfare of cancer patients - Hindustan Times

CARLTON FLETCHER: McConnell is the poster boy for sleazy, partisan politics – The Albany Herald

By Stem Cell Doctors

Oh ... How do you sleep at night?

Ive often complained that I dont understand politics or politicians, but the truth is, I dont really want to.

I dont know what it is that makes men and women who say they want to run for office to help make their country, state, county, city a better place and then find themselves sucked into the madness that is American politics. Its a vocation that takes pretty much decent human beings and turns them into lying, cheating, double-talking cretins who make used car salesmen (no offense) look like followers of Mother Teresa.

Ive found it amazing over the years that politicians the ones who settle in for the long haul, pulling their chairs up to the pork, PAC and lobbyist troughs and just digging in like the pigs and gluttons they become think the American people are so stupid they actually believe their double-talk and bull----. By the same token, however, why would they think otherwise? The American people, who get an up-close, first-hand view of their shenanigans, keep sending them back to Washington, Atlanta, and local government agencies with hardly a second thought.

What? My elected representatives at the highest level cashed in certain stocks and bought up others after they attended a meeting that gave them advance warning of the possible impact of the coronavirus pandemic? Well, thats just good business. What, the businessman we put in the highest office in the land filed 13 bankruptcies and cheated both the American taxpayer and businesses he owed out of millions of dollars? That just shows hes got down the art of the deal, baby.

Did you say the person who wants to be president has changed his mind on important issues depending on which way the wind is blowing on a particular day so many times that he doesnt even know where he stands on those issues? Thats called playing to your base. Everyone does it.

I think Ive made it clear over the years my disdain for Kentucky Sen. Mitch McConnell. From his opposing stem cell research because the extreme right of his party opposed doctors and scientists playing God ... until someone in his family benefited from the science, to proclaiming that the entire Republican party should focus all of its efforts on making sure Barack Obama did not get a second term in office ON THE NIGHT HE WAS ELECTED, McConnell is the poster boy for lousy, self-serving, partisan politics at its worst.

As majority leader of the Senate, McConnell has spent the last 12 years the eight years that Obama was president and the four that Donald Trump has held that office doing nothing but putting conservative judges in office. McConnell conceded that the Democratic-controlled House would not go along with his right-wing agenda, so he has had the Senate do nothing but vote on judges over the last decade-plus. Other than hold a time-wasting impeachment trial that a group of power-tripping and wrong-headed Democrats dreamed up in the House, McConnell has proved to be the epitome of all that is wrong in American politics.

But the turtle man has outdone himself in his hypocritical call to replace recently passed Supreme Court Justice Ruth Bader Ginsburg before her body was even cool following her death from cancer. Wasnt it McConnell, you might ask, who led the charge to keep an Obama Supreme Court nominee from taking a seat on the high court at the end of his tenure in the White House? Yes, but see, McConnell has an answer to such charges of blatant hypocrisy and just out-right lying. He says that when Obama, a Democrat, was in office, the Senate was controlled by Republicans, so there were obvious philosophical differences. Now, with a Republican in the White House and a Republican Senate, he says, its OK.

Meaning? More political blather and bull----.

McConnell has long since proved himself a shameful self-serving opportunist whose traitorous actions in a better time would have landed him in prison or out of the government on his duff. With his disregard for Ginsburgs service, he has also shown himself to be the only passably human ghoul that only the lowest of the low aspire to. The people of Kentucky must be proud ... as they send him back to the trough to misuse and misappropriate more of our hard-earned money.

Email Carlton Fletcher at carlton.fletcher@ albanyherald.com.

See the rest here:
CARLTON FLETCHER: McConnell is the poster boy for sleazy, partisan politics - The Albany Herald

Blood Cancer Awareness Month 2020 – Everyday Health

By Stem Cell Doctors

Professional conferences and meetings offer an opportunity for doctors, researchers, and pharmaceutical professionals to share the latest research and findings on blood cancer. Like some of the runs and walks, many conferences have been postponed or moved to a virtual setting as a result of the COVID-19 pandemic.

Upcoming conferences and meetings include:

The Leukemia & Lymphoma Society held its 2020 National Blood Cancer Conference virtually on September 12 from 11:30 a.m. to 2:45 p.m. EDT. The educational event will be open to caregivers, patients, survivors, and family members of those affected, and review treatment options, emerging therapies, and resources provided by LLS.

LSS will hold its virtual conferences on September 26 hosted by the organizations Georgia/South Carolina region and October 3, hosted by LSSs Metro New York region. Additionally, LLS will host more virtual conferences throughout October and November.

The ASH will hold it's virtual meeting December 5-8 and is the largest conference on blood-related illnesses in the world.

RELATED: New Study Sheds Light on Genetic Differences in Types of Lymphoma

See original here:
Blood Cancer Awareness Month 2020 - Everyday Health

Stem Cell Therapy Market Size, Analytical Overview, Key Players, Growth Factors, Demand, Trends And Forecast to 2027 – The Daily Chronicle

By Embryonic Stem Cells

Allosource

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=33553

Additionally, the report is furnished by the advanced analytical data from SWOT analysis, Porters Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis. The report also provides a detailed analysis of the mergers, consolidations, acquisitions, partnerships, and government deals. Along with this, an in-depth analysis of current and emerging trends, opportunities, threats, limitations, entry-level barriers, restraints and drivers, and estimated market growth throughout the forecast period are offered in the report.

Market Breakdown:

The market breakdown provides market segmentation data based on the availability of the data and information. The market is segmented on the basis of types and applications.

1.Stem Cell Therapy Market, By Cell Source:

Adipose Tissue-Derived Mesenchymal Stem Cells Bone Marrow-Derived Mesenchymal Stem Cells Cord Blood/Embryonic Stem Cells Other Cell Sources

2.Stem Cell Therapy Market, By Therapeutic Application:

Musculoskeletal Disorders Wounds and Injuries Cardiovascular Diseases Surgeries Gastrointestinal Diseases Other Applications

3.Stem Cell Therapy Market, By Type:

Allogeneic Stem Cell Therapy Market, By Application Musculoskeletal Disorders Wounds and Injuries Surgeries Acute Graft-Versus-Host Disease (AGVHD) Other Applications Autologous Stem Cell Therapy Market, By Application Cardiovascular Diseases Wounds and Injuries Gastrointestinal Diseases Other Applications

Request customization of the report @https://reportsglobe.com/need-customization/?rid=33553

The report provides additional analysis about the key geographical segments of the Stem Cell Therapy Market and provides analysis about their current and previous share. Current and emerging trends, challenges, opportunities, and other influencing factors are presented in the report.

Regional analysis includes an in-depth study of the key geographical regions to gain a better understanding of the market and provide an accurate analysis. The regional analysis coversNorth America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.

Objectives of the Report:

To learn more about the report, visit @ https://reportsglobe.com/product/global-stem-cell-therapy-market/

Thank you for reading our report. To learn more about report details or for customization information, please contact us. Our team will ensure that the report is customized according to your requirements.

How Reports Globe is different than other Market Research Providers

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email:[emailprotected]

Web:reportsglobe.com

Read the rest here:
Stem Cell Therapy Market Size, Analytical Overview, Key Players, Growth Factors, Demand, Trends And Forecast to 2027 - The Daily Chronicle

Stem Cell Manufacturing Market 2020 Global Industry Analysis, Size, Growth, Trends, Share, COVID-19 Impact Analysis, and Forecast 2027| Merck Group,…

By Embryonic Stem Cells

Data Bridge Market Research recently introducedGlobal Stem Cell Manufacturing Market Size, Industry Share, Growth, Industry Trends and Forecast To 2027study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2027. Global Stem Cell Manufacturing Market explores effective study on varied sections of Industry like opportunities, size, growth, technology, demand and trend of high leading players. It also provides market key statistics on the status of manufacturers, a valuable source of guidance, direction for companies and individuals interested in the industry. This report showcases the latest trends in the global and regional markets on all critical parameters which include technology, supplies, capacity, production, profit, price, and competition. The growth of the Stem Cell Manufacturing market was mainly driven by the increasing R&D spending across the world, however latest COVID scenario and economic slowdown have changed complete market dynamics.

Stem cell manufacturing is forecasted to grow at CAGR of 6.42% to an anticipated value of USD 18.59 billion by 2027 with factors like rising awareness towards diseases like cancer, degenerative disorders and hematopoietic disorders is driving the growth of the market in the forecast period of 2020-2027.

Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this[emailprotected]https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-stem-cell-manufacturing-market&AB

Stem cell manufacturing has shown an exceptional penetration in North America due to increasing research in stem cell. Increasing research and development activities in biotechnology and pharmaceutical sector is creating opportunity for the stem cell manufacturing market.

The Global Stem Cell Manufacturing Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Stem Cell Manufacturing Market Share analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.

Global Stem Cell Manufacturing Market Segematation By Product (Stem Cell Line, Instruments, Culture Media, Consumables), Application (Research Applications, Clinical Applications, Cell and Tissue Banking), End Users (Hospitals and Surgical Centers, Pharmaceutical and Biotechnology Companies, Clinics, Community Healthcare, Others)

List of TOP KEY PLAYERS in Stem Cell Manufacturing Market Report are

Thermo Fisher Scientific Merck KGaA BD JCR Pharmaceuticals Co., Ltd Organogenesis Inc Osiris Vericel Corporation AbbVie Inc AM-Pharma B.V ANTEROGEN.CO.,LTD Astellas Pharma Inc Bristol-Myers Squibb Company FUJIFILM Cellular Dynamics, Inc RHEACELL GmbH & Co. KG Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Ltd ViaCyte,Inc VistaGen Therapeutics Inc GlaxoSmithKline plc ..

Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart)@https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-manufacturing-market&AB

The report can help to understand the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Stem Cell Manufacturing industry. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. For each manufacturer covered, this report analyzes their Stem Cell Manufacturing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The Global Stem Cell Manufacturing Market Trends, development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.

Global Stem Cell Manufacturing Market Scope and Market Size

Stem cell manufacturing market is segmented on the basis of product, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on product, the stem cell manufacturing market is segmented into stem cell lines, instruments, culture media and consumables. Stem cell lines are further segmented into induced pluripotent stem cells, embryonic stem cells, multipotent adult progenitor stem cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells. Instrument is further segmented into bioreactors and incubators, cell sorters and other instruments.

On the basis of application, the stem cell manufacturing market is segmented into research applications, clinical applications and cell and tissue banking. Research applications are further segmented into drug discovery and development and life science research. Clinical applications are further segmented into allogenic stem cell and autologous stem cell therapy.

On the basis of end users, the stem cell manufacturing market is segmented into hospitals and surgical centers, pharmaceutical and biotechnology companies, research institutes and academic institutes, community healthcare, cell banks and tissue banks and others.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Stem cell manufacturing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for stem cell manufacturing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell manufacturing market. The data is available for historic period 2010 to 2018.

The Global Stem Cell Manufacturing Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of stem cell manufacturing market for global, Europe, North America, Asia Pacific and South America.

Key Insights in the report:

Historical and current market size and projection up to 2025

Market trends impacting the growth of the global taste modulators market

Analyze and forecast the taste modulators market on the basis of, application and type.

Trends of key regional and country-level markets for processes, derivative, and application Company profiling of key players which includes business operations, product and services, geographic presence, recent developments and key financial analysis

For More Information or Query or Customization Before Buying, Visit @https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-stem-cell-manufacturing-market&AB

Opportunities in the market

To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)

The key findings and recommendations highlight crucial progressive industry trends in the Stem Cell manufacturing Market, thereby allowing players to develop effective long term strategies

To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Europe.

To get a comprehensive overview of the Stem Cell manufacturing market.

With tables and figures helping analyses worldwide Global Stem Cell Manufacturing Market Forecast this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. There are 15 Chapters to display the Stem Cell Manufacturing market.

Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Stem Cell Manufacturing market, By Product Type, by application, by end users and regions.

Chapter 2, objective of the study.

Chapter 3, to display Research methodology and techniques.

Chapter 4 and 5, to show the Stem Cell Manufacturing Market Analysis, segmentation analysis, characteristics;

Chapter 6 and 7, to show Five forces (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;

Chapter 8 and 9, to show analysis by regional segmentation[North America, Europe, Asia-Pacific etc ], comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain Analysis

Chapter 10, to identify major decision framework accumulated through Industry experts and strategic decision makers;

Chapter 11 and 12, Stem Cell Manufacturing Market Trend Analysis, Drivers, Challenges by consumer behavior, Marketing Channels

Chapter 13 and 14, about vendor landscape (classification and Market Ranking)

Chapter 15, deals with Stem Cell Manufacturing Market sales channel, distributors, Research Findings and Conclusion, appendix and data source.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand]

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

Our Upcoming Event: Rare Disease and Orphan Drugs |Digital Conference

Go here to see the original:
Stem Cell Manufacturing Market 2020 Global Industry Analysis, Size, Growth, Trends, Share, COVID-19 Impact Analysis, and Forecast 2027| Merck Group,...

Cancer Therapy Market 2020 Size and Share by Growth Opportunities, Segmentation, Regional Insights, Key Trends, Demand and Outlook by 2024 – Verdant…

By Gene Therapy Clinics

Several big pharmaceutical companies, such as Pfizer and Eli lily, have also started these programs to help uninsured patients who are suffering from chronic diseases. Thus, a large number of uninsured patients, suffering from cancer, can also undergo cancer therapies, which is likely to augment the growth of the market.

Scope of the Report:

As per the , cancer therapies are drugs that block the growth and proliferation of cancer, by interfering with specific molecules, such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. These therapies include surgery, radiation therapy, chemotherapy, immunotherapy, etc.

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999546

Key Market Trends:

The Target Therapy Segment is Expected to show the Fastest Growth in the Forecast Period

The target therapy segment is expected to show the highest CAGR of 9.68% during the forecast period. The target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells.

The breast cancer segment is belived to account for the largest market size over the forecast period. This is majorly attrobuted to the higher and continuously increaisng prevalence of breast cancer acoss the world. As per estimates provided by the Breast Cancer Organization in 2018, it is estimated that over 2,66,120 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, along with 63,960 new cases of non-invasive (in situ) breast cancer.

North America Currently Dominates the Cancer Therapy Market and is Expected to Continue in the Forecast Period

North America currently dominates the market for cancer therapy and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased adoption of cancer therapy. The United States holds majority of the market in the North American region, due to the rising prevalence of cancer in the country. According to the National Cancer Institute (NCI), in 2016, 1.6 million people suffered from cancer, and around 0.5 million people died from cancer. This figure indicates that the prevalence of cancer is rapidly increasing in the United States.

Cancer Therapy Market Report contents include:

Purchase this Report (Price 4500 USD for single user license) https://www.industryresearch.co/purchase/13999546

Detailed TOC of Cancer Therapy Market Report 2020-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Increasing Patient Assistance Programs (PAPs) 4.2.2 Growing Government Initiatives for Cancer Awareness 4.2.3 Rising Prevalence of Cancer Worldwide 4.2.4 Strong R&D Initiatives from Key Players 4.3 Market Restraints 4.3.1 Fluctuation in Reimbursement Policies 4.3.2 High Cost of Cancer Therapies 4.4 Porters Five Force Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Treatment Type 5.1.1 Chemotherapy 5.1.2 Targeted Therapy 5.1.3 Immunotherapy 5.1.4 Hormonal Therapy 5.1.5 Other Treatment Types 5.2 By Cancer Type 5.2.1 Blood Cancer 5.2.2 Breast Cancer 5.2.3 Prostate Cancer 5.2.4 Gastrointestinal Cancer 5.2.5 Gynecologic Cancer 5.2.6 Respiratory/Lung Cancer 5.2.7 Other Cancer Types 5.3 By End User 5.3.1 Hospitals 5.3.2 Spcialty Clinics 5.3.3 Cancer and Radiation Therapy Centers 5.4 Geography 5.4.1 North America 5.4.1.1 United States 5.4.1.2 Canada 5.4.1.3 Mexico 5.4.2 Europe 5.4.2.1 Germany 5.4.2.2 United Kingdom 5.4.2.3 France 5.4.2.4 Italy 5.4.2.5 Spain 5.4.2.6 Rest of Europe 5.4.3 Asia-Pacific 5.4.3.1 China 5.4.3.2 Japan 5.4.3.3 India 5.4.3.4 South Korea 5.4.3.5 Australia 5.4.3.6 Rest of Asia-Pacific 5.4.4 Middle East & Africa 5.4.4.1 GCC 5.4.4.2 South Africa 5.4.4.3 Rest of Middle East & Africa 5.4.5 South America 5.4.5.1 Brazil 5.4.5.2 Argentina 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Amgen Inc. 6.1.2 AstraZeneca PLC 6.1.3 Bayer AG 6.1.4 Johnson and Johnson 6.1.5 Merck & Co. Inc. 6.1.6 F. Hoffmann-La Roche AG 6.1.7 Eli Lilly and Company 6.1.8 Novartis AG 6.1.9 Pfizer Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

About Industry Research:

Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Ophthalmic Ultrasound Systems Market Size by Impressive Growth Rate 2020 Business Size, Global Share, Industry Overview by Future Plans, Top Key Players Forecast to 2026 | Report by Industry Research.co

Bouillon Cubes Market Size by Impressive Growth Rate 2020 Business Size, Global Share, Industry Overview by Future Plans, Top Key Players Forecast to 2026 | Report by Industry Research.co

Ultra-Thin Glass Market Growth Analysis by Future Trends 2020 Industry Size by Top Players, Development Plans, Business Share, Revenue and Opportunities till 2026

Foldable Display Market Size by Future Scope 2020 | Global Industry Revenue, Share, Future Demand Status, Growth Segmentations Analysis by Regions Forecast to 2026

Intravenous (IV) Solution Market Growth Analysis by Future Trends 2020 Industry Size by Top Players, Development Plans, Business Share, Revenue and Opportunities till 2026

Brine Concentration Market Size Analysis 2020 Global Industry Scope, Key Players, Top Regions, Current Industry Trend with Growth Rate, CAGR Status Forecast to 2026 | Report by Industry Research.co

Artificial Joint Replacement Market Size Report 2020 Market Dynamics and Developments, Industry Research Report by Top Manufactures, Types, Applications Forecast to 2026

Follow this link:
Cancer Therapy Market 2020 Size and Share by Growth Opportunities, Segmentation, Regional Insights, Key Trends, Demand and Outlook by 2024 - Verdant...

Impact Of Covid-19 on Alpha Thalassemia Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 – Crypto Daily

By Gene Therapy Clinics

Global Alpha Thalassemia Market 2025 Report Provides Porters Five Forces Analysis Illustrates the Potency of Buyers & Suppliers Operating in the Industry & the Quantitative Analysis of The Global Market from 2019 to 2025 is Provided to Determine the Market Potential.

Alpha Thalassemia Market Data and Acquisition Research Study with Trends and Opportunities 2019-2025 The study of Alpha Thalassemia market is a compilation of the market of Alpha Thalassemia broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach. The detailed study also offers a board interpretation of the Alpha Thalassemia industry from a variety of data points that are collected through reputable and verified sources. Furthermore, the study sheds a lights on a market interpretations on a global scale which is further distributed through distribution channels, generated incomes sources and a marginalized market space where most trade occurs.

Request a sample of Alpha Thalassemia Market report @ https://hongchunresearch.com/request-a-sample/61906

Along with a generalized market study, the report also consists of the risks that are often neglected when it comes to the Alpha Thalassemia industry in a comprehensive manner. The study is also divided in an analytical space where the forecast is predicted through a primary and secondary research methodologies along with an in-house model.

The following manufacturers are covered: Bluebird Bio Novartis Kiadis Pharma Acceleron Pharma

Access this report Alpha Thalassemia Market @ https://hongchunresearch.com/report/worldwide-alpha-thalassemia-market-2019-61906

Segment by Regions North America Europe China Japan

Segment by Type Iron Chelating Drugs Gene Therapy

Segment by Application Hospitals Private clinics Other

For a global outreach, the Alpha Thalassemia study also classifies the market into a global distribution where key market demographics are established based on the majority of the market share. The following markets that are often considered for establishing a global outreach are North America, Europe, Asia, and the Rest of the World. Depending on the study, the following markets are often interchanged, added, or excluded as certain markets only adhere to certain products and needs.

Here is a short glance at what the study actually encompasses: Study includes strategic developments, latest product launches, regional growth markers and mergers & acquisitions Revenue, cost price, capacity & utilizations, import/export rates and market share Forecast predictions are generated from analytical data sources and calculated through a series of in-house processes.

However, based on requirements, this report could be customized for specific regions and countries.

To Check Discount of Alpha Thalassemia Market @ https://hongchunresearch.com/check-discount/61906

Major Point of TOC:

Chapter One: Alpha Thalassemia Market Overview

Chapter Two: Global Alpha Thalassemia Market Competition by Manufacturers

Chapter Three: Global Alpha Thalassemia Production Market Share by Regions

Chapter Four: Global Alpha Thalassemia Consumption by Regions

Chapter Five: Global Alpha Thalassemia Production, Revenue, Price Trend by Type

Chapter Six: Global Alpha Thalassemia Market Analysis by Applications

Chapter Seven: Company Profiles and Key Figures in Alpha Thalassemia Business

Chapter Eight: Alpha Thalassemia Manufacturing Cost Analysis

Chapter Nine: Marketing Channel, Distributors and Customers

Chapter Ten: Market Dynamics

Chapter Eleven: Global Alpha Thalassemia Market Forecast

Chapter Twelve: Research Findings and Conclusion

Chapter Thirteen: Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

About HongChun Research: HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details: Jennifer Gray Manager Global Sales + 852 8170 0792 [emailprotected]

Read more:
Impact Of Covid-19 on Alpha Thalassemia Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 - Crypto Daily

Love Island’s Jack Fincham unveils epic weight transformation amid boxing return – Mirror Online

By Platelet Rich Plasma Injections

Love Island's Jack Fincham proudly showed his weight loss after heading back to the boxing gym.

The 26-year-old former salesman, who shot to fame during his stint on Love Island, appeared in high spirits as he showed off his defined abs after just two weeks of training.

Sharing the two photographs with his 2.1 million Instagram followers, Jack confidently showed off the stark difference he was able to achieve after just one extra week of training.

He also shared a video of himself working up a sweat while practising his boxing skills at Sawyer's Boxing.

Last year, Jack turned his attention to his health and fitness after discovering his BMI was verging on being classed as obese.

He piled on the pounds after moving out of his mum's house, having won the Love Island jackpot of 50,000.

Love celebrity gossip? Sign up for the Mirror's daily newsletter for all the juiciest news

Just months after his split from Love Island's Dani Dyer, the former pen salesman had completely transformed his body and shed two stone in the process.

At the time, Jack enlisted the help of the diet plan experts at Protein World to help him get back in shape.

Despite his yo-yoing weight, Jack has always maintained that he was happy and comfortable in his body.

As well as getting back in shape, Jack recently headed back to the hair transplant clinic to get a treatment following his first procedure.

Four months ago, the dad of one underwent his first hair transplant to stimulate hair growth around a scar he has on his scalp.

Speaking at the time he said: ''I ended up killing two birds with one stone and getting a hair transplant on the scar and hairline it dont even hurt man!

"Cant recommend @ksl_clinics enough theyre unreal at what they do!"

Over the past weekend, Jack returned for a platelet-rich plasma treatment where a surgeon made injections around his hairline to boost growth.

Do you have a story to sell? Get in touch with us at webcelebs@trinitymirror.com or call us direct 0207 29 3303

Original post:
Love Island's Jack Fincham unveils epic weight transformation amid boxing return - Mirror Online

Asymmetrex Receives $0.42 Million Award from the NIH-National Heart Lung and Blood Institute to Develop the AlphaSTEM Test for Stem Cell Therapies and…

By Stell Cell Research

Asymmetrex Receives $0.42 Million R&D Award from NIH-NHLBI

BOSTON (PRWEB) September 22, 2020

On the heals of Asymmetrexs recently published peer-reviewed report describing its development of a method for quantifying therapeutic tissue stem cells, on Saturday September 19, the company received a Notice of Award of its first Phase I Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health. Sponsored by the National Heart Lung and Blood Institute, the $0.42 million 1 year award recognizes the potential major impact of Asymmetrexs first-in-kind technology in the stem cell medicine and drug development industries.

Asymmetrex founder and director James L. Sherley, M.D., Ph.D. spent most of Saturday contacting collaborators, contract service providers involved in the project, corporate partners, and industry colleagues who endorsed the grant application to share the news of the award. I couldnt wait until Monday to share this news. No one does biotechnology development and commercialization successfully alone; and Asymmetrex is fortunate to have the kind of support that gets a company to important milestones like this one.

The new funds will accelerate the technical and business development of two applications of the companys AlphaSTEM Test tissue stem cell counting technology. One goal is to evaluate in a head-to-head comparison how the companys computational counting technology relates to the only existing method for specific estimation of the dosage of a therapeutic tissue stem cell.

Human blood stem cells can be estimated specifically by transplanting cells into mice. This test method is expensive, slow (taking 12-16 weeks), and variable. Asymmetrex already established reported in the recent publication that its technology compares well to the published literature for the mouse test, but has significantly less variability. The direct comparison will increase industry confidence and pave the way to raising more financing for advancing the AlphaSTEM Test to clinical evaluations. The companys first clinical application target is determining the dose of stem cells in umbilical cord blood to identify which units will be lifesaving for children after leukemia treatment. In current clinical practice, 15-18% of children receive an ineffective transplant, because the stem cell dose was not known.

The second major milestone accomplished with award funding will be measurement of how well the AlphaSTEM Test identifies drug candidates that are toxic to tissue stem cells, like those in the liver and bone marrow. Drugs that are toxic to tissue stem cells cause chronic organ failure, a life-threatening event for clinical trial patients and a financial catastrophe for a drug development program. Such failures in Phase II and Phase III clinical trials cost the U.S. pharmaceutical industry $4-5 billion in losses each year. Currently, besides these late costly failures, the only way to identify tissue stem cell-toxic drug candidates is with expensive animal toxicology evaluations. Animal evaluations are notorious for their poor ability to predict human toxicities.

The companys seminal report contains preliminary evidence of the AlphaSTEM Tests ability to identify either tissue stem cell-toxic or tissue stem cell-activating compounds inexpensively in cell culture. The latter ability has application for discovery of new compounds that accelerate wound healing and combat effects of aging, including cosmetics. With the new award, Asymmetrex will extend the preliminary studies to the full-scale analyses needed by pharmaceutical companies for their evaluations.

About Asymmetrex

Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. The companys U.S. and U.K. patent portfolio contains biotechnologies that solve the two main technical problems production and quantification that have stood in the way of effective use of human adult tissue stem cells for regenerative medicine and drug development. Asymmetrex markets the first technology for determination of the dose and quality of tissue stem cell preparations (the AlphaSTEM Test) for use in stem cell transplantation therapies and pre-clinical drug evaluations. Asymmetrex is a member company of the Advanced Regenerative Manufacturing Institute BioFabUSA and the Massachusetts Biotechnology Council.

Share article on social media or email:

Link:
Asymmetrex Receives $0.42 Million Award from the NIH-National Heart Lung and Blood Institute to Develop the AlphaSTEM Test for Stem Cell Therapies and...

→←